bendamustine hydrochloride has been researched along with Cytomegaloviral Retinitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ancona, G; Chiamenti, M; Codecà, C; Cona, A; d'Arminio Monforte, A; Ferrari, D; Marchetti, G; Marti, A; Merlini, E; Tesoro, D; Tincati, C | 1 |
| Iwasaki, H; Kadowaki, M; Kohno, K; Takase, K; Yamasaki, S | 1 |
2 other study(ies) available for bendamustine hydrochloride and Cytomegaloviral Retinitis
| Article | Year |
|---|---|
Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets.
Topics: Aged; Antineoplastic Agents, Alkylating; Antiviral Agents; B-Lymphocytes; Bendamustine Hydrochloride; CD8-Positive T-Lymphocytes; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Humans; Male; T-Lymphocyte Subsets; Valganciclovir; Waldenstrom Macroglobulinemia | 2019 |
Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Administration Schedule; Female; Follow-Up Studies; Ganciclovir; Humans; Injections, Intravenous; Intravitreal Injections; Japan; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Opportunistic Infections; Retrospective Studies | 2017 |